The HIV-associated lipodystrophy syndrome: research, results, yet more questions.
Gharakhanian
S
S
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008060:Lipodystrophy / Q000209:etiology* / Q000378:metabolism; D012106:Research; D013577:Syndrome
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors